EX-11.1 3 j3065_ex11d1.htm EX-11.1 Weighted Average Shares Outstanding:

EXHIBIT 11.1

 

ENCHIRA BIOTECHNOLOGY CORPORATION

BASIC AND DILUTED EARNINGS PER SHARE COMPUTATION

YEAR ENDED DECEMBER 31, 1999

 

Weighted Average Shares Outstanding:

TOTAL SHARES

 

 

 

# DAYS
OUTSTANDING

 

 

 

 

 

 

 

 

 

2,179,124

 

x

 

19

 

=

 

41,403,356

 

 

 

 

 

2,179,713

 

x

 

30

 

=

 

65,391,390

 

 

 

 

 

2,180,358

 

x

 

20

 

=

 

43,607,160

 

 

 

 

 

2,180,691

 

x

 

54

 

=

 

117,757,314

 

 

 

 

 

2,182,661

 

x

 

3

 

=

 

6,547,983

 

 

 

 

 

2,315,663

 

x

 

13

 

=

 

30,103,619

 

 

 

 

 

2,328,667

 

x

 

7

 

=

 

16,300,669

 

 

 

 

 

2,355,070

 

x

 

15

 

=

 

35,326,050

 

 

 

 

 

6,150,401

 

x

 

11

 

=

 

67,654,411

 

 

 

 

 

6,569,890

 

x

 

178

 

=

 

1,169,440,420

 

 

 

 

 

6,572,135

 

x

 

15

 

=

 

98,582,025

 

 

 

 

 

 

 

 

 

365

 

 

 

1,692,114,397

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,692,114,397

/365

=

 

4,635,930

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss Per Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss plus dividend accrual plus accretion of offering costs

 

 

 

 

 

 

$

(8,259,546

=

 

$

(1.78

)

Weighted Avg. Shares

 

 

 

 

 

 

4,635,930

 

 

 

 

 

 

 

1



 

ENCHIRA BIOTECHNOLOGY CORPORATION

BASIC AND DILUTED EARNINGS PER SHARE COMPUTATION

YEAR ENDED DECEMBER 31, 2000

 

 

Weighted Average Shares Outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL SHARES

 

 

# DAYS
OUTSTANDING

 

 

 

 

 

 

 

 

 

 

6,572,135

 

x

3

 

=

 

19,716,405

 

 

 

 

 

6,574,135

 

x

7

 

=

 

46,018,945

 

 

 

 

 

6,576,135

 

x

15

 

=

 

98,642,025

 

 

 

 

 

6,578,135

 

x

14

 

=

 

92,093,890

 

 

 

 

 

6,591,135

 

x

1

 

=

 

6,591,135

 

 

 

 

 

6,596,135

 

x

6

 

=

 

39,576,810

 

 

 

 

 

6,624,189

 

x

8

 

=

 

52,993,512

 

 

 

 

 

6,629,189

 

x

1

 

=

 

6,629,189

 

 

 

 

 

6,691,762

 

x

6

 

=

 

40,150,572

 

 

 

 

 

6,706,762

 

x

1

 

=

 

6,706,762

 

 

 

 

 

6,723,424

 

x

3

 

=

 

20,170,272

 

 

 

 

 

6,734,224

 

x

14

 

=

 

94,279,136

 

 

 

 

 

6,734,917

 

x

4

 

=

 

26,939,668

 

 

 

 

 

6,772,512

 

x

6

 

=

 

40,635,072

 

 

 

 

 

7,016,029

 

x

7

 

=

 

49,112,203

 

 

 

 

 

7,018,059

 

x

4

 

=

 

28,072,236

 

 

 

 

 

7,020,039

 

x

17

 

=

 

119,340,663

 

 

 

 

 

7,020,342

 

x

5

 

=

 

35,101,710

 

 

 

 

 

7,021,002

 

x

20

 

=

 

140,420,040

 

 

 

 

 

7,034,921

 

x

46

 

=

 

323,606,366

 

 

 

 

 

7,042,398

 

x

17

 

=

 

119,720,766

 

 

 

 

 

7,054,860

 

x

46

 

=

 

324,523,560

 

 

 

 

 

9,054,860

 

x

45

 

=

 

407,468,700

 

 

 

 

 

9,055,285

 

x

22

 

=

 

199,216,270

 

 

 

 

 

9,056,285

 

x

9

 

=

 

81,506,565

 

 

 

 

 

9,067,075

 

x

20

 

=

 

181,341,500

 

 

 

 

 

9,067,700

 

x

19

 

=

 

172,286,300

 

 

 

 

 

 

 

 

366

 

=

 

2,772,860,272

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,772,860,272

/ 366

=

 

7,576,121

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss Per Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss plus dividend accrual plus accretion of offering costs

 

 

 

 

 

 

$

 (8,336,096

)

=

 

$

   (1.10

)

Weighted Avg. Shares

 

 

 

 

 

 

7,576,121

 

 

 

 

 

 

 

2



 

ENCHIRA BIOTECHNOLOGY CORPORATION

BASIC AND DILUTED EARNINGS PER SHARE COMPUTATION

YEAR ENDED DECEMBER 31, 2001

 

 

Weighted Average Shares Outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL SHARES

 

 

 

# DAYS OUTSTANDING

 

 

 

 

 

 

 

 

9,067,700

 

x

 

5

 

=

45,338,500

 

 

 

 

 

9,077,338

 

x

 

2

 

=

18,154,676

 

 

 

 

 

9,078,463

 

x

 

10

 

=

90,784,630

 

 

 

 

 

9,078,888

 

x

 

22

 

 

199,735,536

 

 

 

 

 

9,079,313

 

x

 

53

 

=

481,203,589

 

 

 

 

 

9,267,993

 

x

 

45

 

=

417,059,685

 

 

 

 

 

9,278,711

 

x

 

82

 

=

760,854,302

 

 

 

 

 

9,280,821

 

x

 

37

 

=

343,390,377

 

 

 

 

 

10,170,739

 

x

 

17

 

=

172,902,563

 

 

 

 

 

10,207,890

 

x

 

23

 

=

234,781,470

 

 

 

 

 

10,231,756

 

x

 

28

 

=

286,489,168

 

 

 

 

 

10,360,026

 

x

 

14

 

=

145,040,364

 

 

 

 

 

10,837,354

 

x

 

10

 

=

108,373,540

 

 

 

 

 

10,843,320

 

x

 

17

 

=

184,336,440

 

 

 

 

 

 

 

 

 

365

 

 

3,488,444,840

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,488,444,840

/365

=

 

9,557,383

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss Per Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss plus dividend accrual plus accretion of offering costs

 

 

 

 

 

 

$

(9,027,019

)

=

 

$

(0.94

)

Weighted Avg. Shares

 

 

 

 

 

 

9,557,383

 

 

 

 

 

 

 

3